Brainstorm Cell Therapeutics Inc.
BCLI
$1.00
$0.011.01%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.86M | -2.13M | -2.43M | -2.11M | -2.90M |
| Total Depreciation and Amortization | 46.00K | 37.00K | 48.00K | 48.00K | 51.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.30M | 133.00K | 322.00K | 157.00K | 503.00K |
| Change in Net Operating Assets | 613.00K | 637.00K | 1.32M | 799.00K | -1.15M |
| Cash from Operations | -895.00K | -1.32M | -740.00K | -1.10M | -3.50M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | 280.00K | 582.00K | -- | -- |
| Total Debt Repaid | -125.00K | -- | 199.00K | -- | -1.10M |
| Issuance of Common Stock | 1.02M | 970.00K | -- | 313.00K | 3.35M |
| Repurchase of Common Stock | -- | -- | -1.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | -- | 450.00K |
| Cash from Financing | 898.00K | 1.25M | 780.00K | 313.00K | 2.70M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.00K | -70.00K | 40.00K | -789.00K | -801.00K |